Mindfulness: what the evidence says

Updated · every claim quoted from its source

Drafted with AI, claims automatically checked against cited sources

Short answer

Mindfulness-based programmes such as MBSR and MBCT have modest average effects on stress, anxiety and depression. They beat waitlist controls, match evidence-based treatments, and do not outperform all active treatments; a minority report adverse effects.

Short answer

Mindfulness-based programmes such as MBSR and MBCT show real but modest average benefits for stress, anxiety and depression [C3][C4]. They outperform waitlist and passive controls and match evidence-based treatments, though they do not beat every active treatment [C6][C7]. A minority of people report adverse effects from meditation practice [C11].

What it is and how it shows up

Mindfulness means paying attention to present-moment experience as it unfolds, rather than dwelling on the past or anticipating the future. Structured mindfulness programmes teach this through guided meditation exercises and short everyday practices, usually in group settings led by a teacher over several weeks [C10]. One well-studied example is mindfulness-based cognitive therapy (MBCT), a group-based programme that combines systematic training in mindfulness meditation with cognitive-behavioral methods to reduce relapse or recurrence of major depressive disorder [C2].

Research on how these programmes work points to changed reactivity rather than relaxation alone. A meta-analysis of mediation studies found strong, consistent evidence for cognitive and emotional reactivity, and moderate, consistent evidence for mindfulness, rumination and worry, as mechanisms through which mindfulness-based interventions affect mental health outcomes [C1]. In practice this means the training appears to change how people relate to their own thoughts and feelings, for example by interrupting repetitive negative thinking, rather than removing stressors from their lives [C1]. The same review cautions that most mediation studies have key methodological shortcomings, so these mechanism findings are consistent but not definitive [C1].

Programmes are used in two broad settings. In clinical populations they are offered alongside other psychological care for conditions such as depression, pain conditions, smoking and addictive disorders [C7][C2]. In non-clinical settings they are offered to community adults for prevention and stress reduction, typically as group-based, teacher-led courses [C10]. People usually start them for stress, low mood or anxiety, and the programmes are designed to be practised regularly between sessions as well as during them [C10][C2].

What research shows by approach

The evidence differs by programme and by comparison group, so this section walks through the main approaches one at a time.

Mindfulness-based stress reduction in healthy adults

Mindfulness-based stress reduction (MBSR) is the original structured programme, built around meditation, body scans and gentle movement. In healthy adults, across 29 studies with 2668 participants, MBSR was moderately effective in reducing stress, depression, anxiety and distress and in improving quality of life [C4].

The overall meta-analytic picture

Pooling all study designs, a comprehensive meta-analysis of 209 studies with 12,145 participants found mindfulness-based therapy moderately effective in pre-post comparisons and versus waitlist controls, with lower effect sizes versus other active treatments and no difference from traditional CBT or behavioral therapies [C3]. A separate review of mindfulness meditation programs for stress-related outcomes, covering 47 trials with 3515 participants, graded the evidence for improved anxiety and depression as moderate, with effect sizes such as 0.38 at 8 weeks for anxiety, and concluded that meditation can result in small to moderate reductions of multiple negative dimensions of psychological stress [C5].

Mindfulness-based interventions in clinical populations

In clinical populations, a meta-analysis of 142 samples with 12,005 participants found mindfulness-based interventions superior to no treatment, minimal treatment and active controls at post-treatment, and not different from evidence-based treatments [C7]. At follow-up the pattern was similar, with mindfulness-based interventions still superior to no treatment and to active controls [C7]. The most consistent evidence was for depression, pain conditions, smoking and addictive disorders [C7].

Compared with other active treatments

Against active comparison groups the picture is mixed. One review found no evidence that meditation programs were better than any active treatment [C6]. Another found mindfulness-based interventions superior to specific active controls (d = 0.23) but not different from evidence-based treatments (d = -0.004) [C6][C7]. The honest summary is that mindfulness programmes are comparable to established psychological treatments, not clearly better [C6][C7].

MBCT for preventing depression relapse

For people with recurrent depression in remission, MBCT has the strongest specific evidence. An individual patient data meta-analysis of 9 studies with 1258 patients found that MBCT reduced the risk of depressive relapse within a 60-week follow-up compared with non-MBCT care (hazard ratio 0.69, 95% CI 0.58-0.82), and comparisons with active treatments also suggested a reduced risk (hazard ratio 0.79, 95% CI 0.64-0.97) [C8]. An earlier meta-analysis of six randomized controlled trials with 593 participants found a risk ratio of 0.66, a relative risk reduction of 34% overall and 43% among participants with three or more previous episodes [C9].

Prevention in community adults

In non-clinical settings, group-based teacher-led mindfulness-based programmes reduced average psychological distress versus passive control groups with a small to moderate effect (SMD -0.32) in an individual participant data meta-analysis of fifteen trials with 2,371 participants [C10]. The trials involved community adults who volunteered for the programmes and were moderately distressed on average, so the result describes prevention in the general community rather than treatment of a diagnosed disorder [C10].

Adverse effects of meditation

Meditation is not risk-free. Across 83 studies with 6703 participants, the total prevalence of adverse events was 8.3% (95% CI 0.05-0.12), most commonly anxiety (33%) and depression (27%) [C11]. The occurrence of adverse events during or after meditation practices is not uncommon [C11].

Limitations and uncertainty

Several limits matter. Most effect sizes come from comparisons with waitlist or passive controls, so part of the measured benefit may reflect attention, expectation and group contact rather than the mindfulness technique itself; against active treatments the advantage shrinks or disappears [C6][C10]. The mediation evidence, while consistent, rests on studies with key methodological shortcomings that preclude robust conclusions [C1]. Adverse-event prevalence varied considerably across types of studies, and trials often do not monitor adverse events systematically [C11]. The prevention evidence comes from community adults who volunteer for programmes, with missing outcome data in some trials, and the authors call for more research on individual-level variability [C10]. The relapse-prevention estimate rests on a 60-week follow-up [C8]. Pooled averages in all of these meta-analyses describe groups, not any one person's response [C3][C10]. Many trials rely on self-reported symptoms, and the programmes, teachers and control conditions differ widely from study to study, which makes the pooled numbers hard to translate into an expectation for one person [C5][C10].

When to see a professional

If stress, anxiety or low mood persist for weeks, impair work or relationships, or worsen during or after meditation practice, that is a reason to see a qualified clinician rather than relying on self-help alone [C11]. This is also true if you have had several episodes of depression: structured programmes such as MBCT are studied for relapse prevention, but they complement clinical care rather than substitute for it [C8][C2]. A clinician can assess what is going on and discuss evidence-based options, including structured programmes such as MBCT where appropriate [C2][C7]. This page summarises research findings; it is not a diagnosis and not a treatment plan.

FAQ

What is mindfulness in plain terms?

Mindfulness is attention to present-moment experience as it happens. Structured programmes such as MBCT combine systematic mindfulness meditation training with cognitive-behavioral methods [C2], and mediation analyses point to reduced cognitive and emotional reactivity, less rumination and less worry as the mechanisms at work [C1]. In everyday terms, the practice is about noticing what is happening now instead of automatically reacting to it [C1].

Does mindfulness reduce stress and anxiety?

On average, yes, by a modest amount. MBSR was moderately effective for stress, depression, anxiety and distress in healthy adults [C4], and mindfulness meditation programs showed moderate evidence of improved anxiety and depression across 47 trials [C5]. Across all designs, mindfulness-based therapy was moderately effective overall, with the strongest gains seen against waitlist controls rather than active treatments [C3][C6].

Is mindfulness better than other treatments?

Not clearly. Mindfulness-based interventions match evidence-based treatments [C7] and were superior to specific active controls (d = 0.23) in one meta-analysis [C6], but another review found no evidence that meditation programs were better than any active treatment [C6]. Treat them as a credible option among several, not a superior one [C6][C7].

Can MBCT prevent depression relapse?

In trials with recurrent depression, yes on average: hazard ratio 0.69 versus non-MBCT care within a 60-week follow-up in an individual patient data meta-analysis [C8], and a relative risk reduction of 34% (43% with three or more previous episodes) in an earlier meta-analysis of six randomized controlled trials [C9].

Can meditation have side effects?

Yes, in a minority. The total prevalence of adverse events was 8.3% across 83 studies with 6703 participants, most commonly anxiety (33%) and depression (27%) [C11], and such events are not uncommon [C11]. The prevalence varied considerably across types of studies [C11]. If practice consistently worsens how you feel, mention it to a clinician [C11].

When should I talk to a professional about mindfulness practice?

If you have persistent or severe symptoms, if meditation practice brings up distressing experiences, or if you have thoughts of self-harm, contact a qualified clinician or local emergency services rather than managing it alone [C11].

Self-help information does not replace a clinician; people with severe or persistent symptoms, or thoughts of self-harm, should contact a professional or local emergency services.

How certain is this?

Most effect sizes come from comparisons with waitlist or passive controls, so part of the benefit may reflect attention and expectation; against active treatments effects are smaller or absent. Mediation studies have methodological shortcomings, adverse events are under-reported in many trials, and individual responses vary widely.

Claims and evidence

  1. [C1]Context-dependent

    A meta-analysis of mediation studies found strong, consistent evidence for cognitive and emotional reactivity, and moderate, consistent evidence for mindfulness, rumination and worry, as mechanisms through which mindfulness-based interventions affect mental health outcomes.

    “This review identified strong, consistent evidence for cognitive and emotional reactivity, moderate and consistent evidence for mindfulness, rumination, and worry, and preliminary but insufficient evidence for self-compassion and psychological flexibility as mechanisms underlying MBIs.”

    [S1] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “TSSEM demonstrated evidence for mindfulness, rumination and worry as significant mediators of the effects of MBIs on mental health outcomes.”

    [S1] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Most reviewed mediation studies have several key methodological shortcomings which preclude robust conclusions regarding mediation.”

    [S1] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Mediation studies have key methodological shortcomings, so mechanism evidence is consistent but not definitive.

  2. [C2]Context-dependent

    Mindfulness-based cognitive therapy (MBCT) is a group-based programme that combines systematic training in mindfulness meditation with cognitive-behavioral methods to reduce relapse or recurrence of major depressive disorder.

    “Mindfulness-based cognitive therapy (MBCT) is a group-based clinical intervention program designed to reduce relapse or recurrence of major depressive disorder (MDD) by means of systematic training in mindfulness meditation combined with cognitive-behavioral methods.”

    [S2] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Description of the programme structure; it does not by itself show outcomes.

  3. [C3]Context-dependent

    Across 209 studies with 12,145 participants, mindfulness-based therapy was moderately effective in pre-post comparisons (Hedge's g = .55) and versus waitlist controls (g = .53), with lower effect sizes versus other active treatments (g = .33) and other psychological treatments (g = .22), and no difference from traditional CBT or behavioral therapies (g = -.07).

    “A total of 209 studies (n=12,145) were included.”

    [S3] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Effect-size estimates suggested that MBT is moderately effective in pre-post comparisons (n=72; Hedge's g=.55), in comparisons with waitlist controls (n=67; Hedge's g=.53), and when compared with other active treatments (n=68; Hedge's g=.33)”

    [S3] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “including other psychological treatments (n=35; Hedge's g=.22)”

    [S3] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “MBT did not differ from traditional CBT or behavioral therapies (n=9; Hedge's g=-.07) or pharmacological treatments (n=3; Hedge's g=.13).”

    [S3] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Pooled averages across heterogeneous studies, populations and control groups; pre-post comparisons have no control group.

  4. [C4]Context-dependent

    In healthy adults, mindfulness-based stress reduction across 29 studies with 2668 participants was moderately effective in reducing stress, depression, anxiety and distress and in improving quality of life.

    “A total of 29 studies (n=2668) were included.”

    [S4] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “MBSR is moderately effective in reducing stress, depression, anxiety and distress and in ameliorating the quality of life of healthy individuals”

    [S4] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Non-clinical samples only; the authors note more research is needed to identify the most effective elements of MBSR.

  5. [C5]Context-dependent

    Across 47 trials with 3515 participants, mindfulness meditation programs had moderate evidence of improved anxiety (effect size 0.38 at 8 weeks and 0.22 at 3-6 months) and depression (0.30 at 8 weeks and 0.23 at 3-6 months), and can result in small to moderate reductions of multiple negative dimensions of psychological stress.

    “After reviewing 18 753 citations, we included 47 trials with 3515 participants.”

    [S5] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Mindfulness meditation programs had moderate evidence of improved anxiety (effect size, 0.38 [95% CI, 0.12-0.64] at 8 weeks and 0.22 [0.02-0.43] at 3-6 months), depression (0.30 [0.00-0.59] at 8 weeks and 0.23 [0.05-0.42] at 3-6 months)”

    [S5] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “meditation programs can result in small to moderate reductions of multiple negative dimensions of psychological stress”

    [S5] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Strength-of-evidence grading, not a pooled effect size; outcomes were mostly self-reported and trials varied in control type.

  6. [C6]Debated

    Against active comparison groups the evidence is mixed: one systematic review found no evidence that meditation programs were better than any active treatment, while a meta-analysis of 142 samples with 12,005 participants found mindfulness-based interventions superior to specific active controls (d = 0.23) but not different from evidence-based treatments (d = -0.004).

    “We found no evidence that meditation programs were better than any active treatment (ie, drugs, exercise, and other behavioral therapies).”

    [S5] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “A total of 142 non-overlapping samples and 12,005 participants were included.”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “At post-treatment, mindfulness-based interventions were superior to no treatment (d=0.55), minimal treatment (d=0.37), non-specific active controls (d=0.35), and specific active controls (d=0.23).”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Mindfulness conditions did not differ from evidence-based treatments (d=-0.004).”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: The two reviews used different control classifications and outcome definitions, so the disagreement may partly reflect methods.

  7. [C7]Context-dependent

    In clinical populations, mindfulness-based interventions were superior to no treatment (d = 0.55), minimal treatment (d = 0.37), non-specific active controls (d = 0.35) and specific active controls (d = 0.23) at post-treatment, with the most consistent evidence for depression, pain conditions, smoking and addictive disorders.

    “A total of 142 non-overlapping samples and 12,005 participants were included.”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “At post-treatment, mindfulness-based interventions were superior to no treatment (d=0.55), minimal treatment (d=0.37), non-specific active controls (d=0.35), and specific active controls (d=0.23).”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “At follow-up, mindfulness-based interventions were superior to no treatment conditions (d=0.50), non-specific active controls (d=0.52), and specific active controls (d=0.29).”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Effects on specific disorder subgroups showed the most consistent evidence in support of mindfulness for depression, pain conditions, smoking, and addictive disorders.”

    [S6] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Disorder-specific effects vary; equivalence with evidence-based treatments does not mean superiority over them.

  8. [C8]Context-dependent

    In an individual patient data meta-analysis of 9 studies with 1258 patients with recurrent depression, MBCT reduced the risk of depressive relapse within a 60-week follow-up compared with non-MBCT care (hazard ratio 0.69, 95% CI 0.58-0.82), and comparisons with active treatments also suggested a reduced risk (hazard ratio 0.79, 95% CI 0.64-0.97).

    “resulting in 9 studies with individual patient data, which were included in the quantitative synthesis”

    [S7] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Of the 1258 patients included”

    [S7] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “patients receiving MBCT had a reduced risk of depressive relapse within a 60-week follow-up period compared with those who did not receive MBCT (hazard ratio, 0.69; 95% CI, 0.58-0.82)”

    [S7] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “comparisons with active treatments suggest a reduced risk of depressive relapse within a 60-week follow-up period (hazard ratio, 0.79; 95% CI, 0.64-0.97)”

    [S7] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Follow-up limited to 60 weeks; patients were in full or partial remission, so results do not apply to acute depression.

  9. [C9]Context-dependent

    An earlier meta-analysis of six randomized controlled trials with 593 participants found MBCT significantly reduced relapse/recurrence risk (risk ratio 0.66), a relative risk reduction of 34% overall and 43% among participants with three or more previous episodes.

    “Six randomized controlled trials with a total of 593 participants were included in the meta-analysis.”

    [S2] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “MBCT significantly reduced the risk of relapse/recurrence with a risk ratio of 0.66 for MBCT compared to treatment as usual or placebo controls, corresponding to a relative risk reduction of 34%.”

    [S2] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “In a pre-planned subgroup analysis the relative risk reduction was 43% for participants with three or more previous episodes, while no risk reduction was found for participants with only two episodes.”

    [S2] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Small evidence base of six trials; no risk reduction was found for participants with only two episodes.

  10. [C10]Context-dependent

    In non-clinical adults, group-based teacher-led mindfulness-based programmes reduced average psychological distress versus passive control groups with a small to moderate effect (SMD -0.32, 95% CI -0.41 to -0.24) in an individual participant data meta-analysis of fifteen trials with 2,371 participants.

    “Fifteen trials were eligible, 13 trialists shared IPD (2,371 participants representing 8 countries, median age 34 years-old, 71% women, moderately distressed on average, 20% missing outcome data).”

    [S8] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “In comparison with passive control groups, MBPs reduced average distress between one- and six-months post-intervention with a small to moderate effect size (standardised mean difference (SMD) -0.32; 95% confidence interval (CI) -0.41 to -0.24”

    [S8] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “Group-based teacher-led MBPs generally reduce psychological distress among community adults who volunteer to receive this type of intervention. More research is needed to identify sources of variability in outcomes at an individual level.”

    [S8] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Volunteering community adults only, passive controls, and 20% missing outcome data; individual-level variability remains unexplained.

  11. [C11]Context-dependent

    Meditation is not risk-free: across 83 studies with 6703 participants, the total prevalence of adverse events was 8.3% (95% CI 0.05-0.12), most commonly anxiety (33%) and depression (27%), and such events are not uncommon.

    “83 of which met the inclusion criteria for MAEs with a total of 6703 participants who undertook meditation practice”

    [S9] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “The total prevalence of adverse events was 8.3% (95% CI 0.05-0.12), though this varied considerably across types of studies”

    [S9] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “The most common AEs were anxiety (33%, 18), depression (27%, 15) and cognitive anomalies (25%, 14)”

    [S9] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    “the occurrence of AEs during or after meditation practices is not uncommon”

    [S9] · Systematic review / meta-analysis · Conflicts of interest: Not stated in abstract

    Limitation: Prevalence varied considerably across study types, and randomized trials often do not monitor adverse events systematically.

Sources

  1. [S1] Systematic review / meta-analysis. PMID 25689576 · DOI 10.1016/j.cpr.2015.01.006
  2. [S2] Systematic review / meta-analysis. PMID 21802618 · DOI 10.1016/j.cpr.2011.05.002
  3. [S3] Systematic review / meta-analysis. PMID 23796855 · DOI 10.1016/j.cpr.2013.05.005
  4. [S4] Systematic review / meta-analysis. PMID 25818837 · DOI 10.1016/j.jpsychores.2015.03.009
  5. [S5] Systematic review / meta-analysis. PMID 24395196 · DOI 10.1001/jamainternmed.2013.13018
  6. [S6] Systematic review / meta-analysis. PMID 29126747 · DOI 10.1016/j.cpr.2017.10.011
  7. [S7] Systematic review / meta-analysis. PMID 27119968 · DOI 10.1001/jamapsychiatry.2016.0076
  8. [S8] Systematic review / meta-analysis. PMID 37867573 · DOI 10.1038/s44220-023-00081-5
  9. [S9] Systematic review / meta-analysis. PMID 32820538 · DOI 10.1111/acps.13225

More in psychology

Educational information, not medical advice. If anxiety or low mood is severe or persistent, or you have thoughts of self-harm, contact a qualified professional or local emergency services.

More psychology topics · ONDA Science